You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bridging therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,

Not yet recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • +6 more
  • Bridging radiation therapy
  • +2 more
  • (no location specified)
Jan 4, 2023

Hyperthyroidism/Thyrotoxicosis Trial in Cheras (radioactive iodine)

Completed
  • Hyperthyroidism/Thyrotoxicosis
  • radioactive iodine
  • Cheras, Kuala Lumpur, Malaysia
    Hospital Canselor Tuanku Muhriz
Aug 20, 2022

Diffuse Large B Cell Lymphoma, CAR-T, Radiotherapy Trial (ultra-fraction radiotherapy)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • ultra-fraction radiotherapy
  • (no location specified)
Aug 22, 2022

B-cell Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Apr 4, 2022

Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Tampa (Comprehensive Ablative Bridging Irradiation (CABI),

Recruiting
  • Large B-cell Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • Comprehensive Ablative Bridging Irradiation (CABI)
  • Chimeric Antigen Receptor T-Cell Therapy
  • Tampa, Florida
    Moffitt Cancer Center
Oct 26, 2023

Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma Trial in Boston (Adaptive Bridging Radiation Therapy (ABRT))

Not yet recruiting
  • Lymphoma, B-Cell
  • +7 more
  • Adaptive Bridging Radiation Therapy (ABRT)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 16, 2023

Large B-cell Lymphoma, B-cell Lymphoma Trial in Houston (Magrolimab, Rituximab, CAR T leukapheresis)

Not yet recruiting
  • Large B-cell Lymphoma
  • B-cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2023

Relapsed/Refractory Aggressive B-Cell Malignancies Trial (ONCT-808, Bridging Therapy)

Not yet recruiting
  • Relapsed/Refractory Aggressive B-Cell Malignancies
  • ONCT-808
  • Bridging Therapy
  • (no location specified)
Jan 19, 2023

Thrombectomy, Ischemic Stroke, Large-Artery Atherosclerosis (Embolus/Thrombosis) Trial in Alexandria (Trevo and or Merci devices

Completed
  • Thrombectomy
  • +2 more
  • Trevo and or Merci devices for stent retreival
  • +2 more
  • Alexandria, Egypt
    Alexandria University Faculty of Medicine
Dec 11, 2021

Follicular Lymphoma (FL) Trial (biological, drug, other)

Not yet recruiting
  • Follicular Lymphoma (FL)
  • Tisagenlecleucel
  • +4 more
  • (no location specified)
May 24, 2023

Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • BTK inhibitor
  • PD-1 inhibitor
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
May 20, 2023

B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Azacitidine Injection
  • +2 more
  • (no location specified)
Oct 15, 2023

Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)

Not yet recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Biospecimen Collection
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Mar 24, 2023

Alcohol Use Disorder Trial in Philadelphia (Naltrexone Pill)

Not yet recruiting
  • Alcohol Use Disorder
  • Naltrexone Pill
  • Philadelphia, Pennsylvania
    Albert Einstein Medical Center Philadelphia
Jan 27, 2022

Hepatocellular Carcinoma Trial in Maywood, Portland, Philadelphia (TACE transarterial chemoembolization, stereotatic body

Active, not recruiting
  • Hepatocellular Carcinoma
  • TACE transarterial chemoembolization
  • stereotatic body radiotherapy (SBRT)
  • Maywood, Illinois
  • +2 more
Dec 3, 2021

SAfety and EFficacy of Bridging Antithrombotic Therapy During

Recruiting
  • Coronary Artery Disease
    • Beijing, Beijing, China
      Beijing Anzhen Hospital, Capital Medical University
    Nov 5, 2021

    Smoking Cessation Trial in Burlington (Financial Incentives (FI) and Nicotine Replacement Therapy (NRT))

    Recruiting
    • Smoking Cessation
    • Financial Incentives (FI) and Nicotine Replacement Therapy (NRT)
    • Burlington, Vermont
      University of Vermont Medical Center
    Feb 10, 2023

    Non Hodgkin's Lymphoma Trial in China (Chidamide, Fludarabine and cyclophosphamide, Anti-CD19 CAR-T cells)

    Recruiting
    • Non Hodgkin's Lymphoma
    • Beijing, Beijing, China
    • +12 more
    Jun 9, 2022

    Non-Hodgkin Lymphoma, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in United States (radiation,

    Recruiting
    • Non-Hodgkin Lymphoma
    • +2 more
    • Bridging radiotherapy (BRT)
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 24, 2023

    Prostatic Tumors Trial in United States (JNJ-75229414, Bridging Therapy)

    Recruiting
    • Prostatic Neoplasms
    • Duarte, California
    • +10 more
    Aug 2, 2022

    Severe Aplastic Anemia (SAA) Trial (Romiplostim, Antithymocyte Globulin, Cyclosporine A)

    Not yet recruiting
    • Severe Aplastic Anemia (SAA)
    • (no location specified)
    Sep 2, 2022

    Experimental Blood Test to Track Liver Cancer

    Recruiting
    • Hepatocellular Carcinoma
      • Philadelphia, Pennsylvania
        Thomas Jefferson University Hospital
      Aug 15, 2022

      ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell

      Recruiting
      • Relapsed Non Hodgkin Lymphoma
      • Refractory Non-Hodgkin Lymphoma
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University
        Jun 7, 2021

        Stroke, Acute, Stroke, Ischemic Trial in China (rhTNK-tPA, Endovascular treatment)

        Recruiting
        • Stroke, Acute
        • Stroke, Ischemic
        • Chongqing, Chongqing, China
        • +4 more
        Oct 15, 2022

        Myocardial Bridging Trial in Stanford (Nebivolol, Diltiazem, Placebo)

        Recruiting
        • Myocardial Bridging
        • Stanford, California
          Stanford University
        Oct 19, 2020